Xifaxan 550 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FMBBL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,115
Award facts
- Contract value 100% obligated
- $13,114.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $13,114.84. This firm fixed-price delivery order, with an ultimate completion date of October 29, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The company's extensive portfolio with the DLA demonstrates its capability to deliver a broad range of pharmaceutical products across multiple therapeutic domains through competitive procurement. This specific delivery order for Xifaxan—an antibiotic medication—exemplifies the company's role in supplying essential pharmaceutical commodities to federal healthcare systems through established indefinite delivery contract vehicles.
Quick answers
Who was awarded contract SPE2DB26FMBBL?
SPE2DB26FMBBL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FMBBL worth?
The government has obligated $13,115 on SPE2DB26FMBBL.
Is contract SPE2DB26FMBBL an order under another contract?
Yes. SPE2DB26FMBBL is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB26FMBBL competed?
The extent of competition for SPE2DB26FMBBL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award